[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Goa, ivermectin for all adults", "description": "UK SAGE, Emergency meeting over rapid spread of Indian variant\n17th May\n21st June\n\nhttps://www.telegraph.co.uk/news/2021/05/12/rapid-spread-indian-covid-variant-prompts-emergency-sage-meeting/\n\nUK, 45 days first discovered\n\nCases, = 727\n\nAbout 3 times quicker than SA variant\n \nBolton, epicentre, cases doubled in past week\n\nBlackburn, Bedford, South Northamptonshire, Sefton, Tynemouth, Glasgow\n\nMP for Bolton, Yasmin Quareshi\n\nResidents had been slow to get vaccinated\n\nReact study, Imperial College London\n\nInfections are spreading more rapidly amongst the Asian community, and in some of the other groups in the population\n\nAndy Burnham\n\nRequested  Joint Committee on Vaccination and Immunisation, all over-16s in Bolton, and Greater Manchestee\n\nto mitigate the risks of spread in those communities where we are seeing more transmission\n\nCases inked to international travel\n\nProf James Naismith, Rosalind Franklin Institute\n\nWe should view it as a country-wide problem\n\nLocalised restrictions unlikely to work\n\nbut maybe Sage already have that data \n\nbefore we continue to unlock\n\nGoa and ivermectin prophylaxis\n\nhttps://science.thewire.in/health/ivermectin-covid-19-merck-soumya-swaminathan-who/\n\nhttps://www.firstpost.com/health/goa-prescribes-ivermectin-for-all-above-18-to-fight-covid-19-as-experts-flag-concern-all-you-need-to-know-9611751.html\n\nhttps://www.forbes.com/sites/siladityaray/2021/05/11/indian-state-will-offer-ivermectin-to-entire-adult-population---even-as-who-warns-against-its-use-as-covid-19-treatment/\n\nhttps://www.timesnownews.com/india/article/ivermectin-to-all-above-18-goa-approves-new-covid-19-treatment-protocol/755160\n\nhttps://indianexpress.com/article/india/ivermectin-goa-world-health-organisation-covid-7310664/\n\nFor all those above the age of 18\n\nIrrespective of Covid-19 symptoms\n\n12 mg of ivermectin for five days\n\nState Health Minister Vishwajit Rane\n\nGoa would be the first state in the country to administer, to its adult citizens\n\nas a step towards protecting lives\n\nState government, drug will be given to the people through its chain of health centres\n\nThere have been studies in journals of therapeutics, \n\nthere have been studies in the US, UK, Japan, Germany\n\nthat when this is administered in advance\n\nwhen the entire population is administered this treatment\n\ntheir mortality rate fell and effects of Covid-19 on that individual were also less\n \nAll our doctors and experts, the chief minister have unanimously decided to go ahead with this\n\nWe should go ahead and give it to the population\n\nIt\u2019s a must\n\nDr Vinayak Buvaji, Goa chapter, Indian Medical Association\n\nTreatment should not be given for a short period of five days\n\nbut should ideally be continued till the pandemic is brought under control\n\nThe ideal regimen of ivermectin is to administer it on the first, third and seventh day\n\nand then continue it once a week till the pandemic is brought under control\n\nGiving the tablets only for five days will not be impactful\n\nThe people weighing below 60 kg should be given the 12 mg dose of ivermectin\n\nwhile those above 60 kg should be given the 18 mg dose\n\nDr Buvaji writing to state Health Department to change the proposed ivermectin dose protocol\n\nChief Scientist, World Health Organization, Dr Soumya Swaminathan\n\nSafety and efficacy are important when using any drug for a new indication\n\nWHO recommends against the use of ivermectin for #COVID19 except within clinical trials\n\nMerck Statement on Ivermectin use During the COVID-19 Pandemic\n\nhttps://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/\n\nNo scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies \n\nNo meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease\n\nA concerning lack of safety data in the majority of studies\n\nNext UK vaccination group\n\nhttps://www.telegraph.co.uk/news/2021/05/12/covid-jabs-under-40s-tomorrow/\n\nAppointments open to 38 and 39 year olds\n\nForty something, 75%\n\nJoint Committee on Vaccination and Immunisation, offered Phizer or Moderna\n\nLikewise for pregnant women\n\nText messages\n\nNepal\n\nCases, + 9,000\n\nhttps://www.bbc.co.uk/news/live/uk-57069295\n\nOxygen shortage, 16 deaths\n\nHospitals in Lumbini province\n\nIndia restricted exports\n\nEurope\n\nhttps://www.bbc.co.uk/news/live/uk-57069295\n\nHungary \n\nVaccinations to 16-18-year-olds this morning\n\nNeeded for bars or music festivals\n\nGermany\n\nHigh demand for the Oxford-AstraZeneca vaccine\n\nAll allowed\n\nAppointments have had to be cancelled\n\nBDK police union, Sebastian Fiedler, forged vaccination passports\n\nSpan and Portugal\n\nMass sporting attendance from 19th May\n\n30% per stadium in low prevalence areas\n\nF\u00e1tima, 7,500 pilgrims", "link": "https://www.youtube.com/watch?v=HFcF2ppAeR4", "date_published": "2021-05-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "CDC comes up to date", "description": "UK\nhttps://coronavirus.data.gov.uk\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nCases, + 2,357 + 2,474 = 4,439,691\n\nDeaths, + 4 + 20 = 127,629\n\nDeaths, + 290 (7 days) = 151,533\n\nVaccinations\n\nhttps://coronavirus.data.gov.uk/details/vaccinations\n\nFirst dose, + 115,053 = 35,587,348 (67.6%)\n\nSecond dose, + 231,835 = 18,088,385 (34.3%)\n\nFrance\n\nhttps://www.aljazeera.com/news/2021/5/10/france-records-20-cases-of-indian-covid-19-variant\n\nIndia variant, 20 cases, 5 clusters\n\nOlivier Veran, Health Minister\n\nReopen bars and restaurants for outdoor service on May 19\n\nVaccinations\n\nOne dose, 17.8 million (26.6%)\n\nSecond dose, 7.8 million\n\nITU cases\n\nSaturday, 5,005\n\nSunday, 4,971\n\nFirst drop below, 5,000 since March 29\n\nUS\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nhttps://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use\n\nU.S. Food and Drug Administration\n\nExpanded emergency use authorization\n\nPfizer-BioNTech COVID-19 Vaccine\n\n12 to 15 years of age\n\nJanet Woodcock, (FDA)\n\nallows for a younger population to be protected\n\nbringing us closer to returning to a sense of normalcy\n\nand to ending the pandemic\n\nMarch 1, 2020 through April 30, 2021\n\n1.5 million COVID-19 cases in individuals 11 to 17 years\n\nTwo doses, three weeks apart\n\nPotential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks\n\n\n \n\nScientific Brief: SARS-CoV-2 Transmission (7th May)\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/sars-cov-2-transmission.html\n\nhttps://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted\n\nSARS-CoV-2 is transmitted by exposure to infectious respiratory fluids\n\nPeople release respiratory fluids\n\nInfection depends on concentration of viral particles\n\nThree principal ways: \n\nInhalation\n\nMucous membranes depositions\n\nTouching mucous membranes\n\nFactors in inoculum\n\nAirstream \n\nThermal layering and \n\nInitial jetting of exhalations\n\nEnclosed spaces\n\nIncreased exhalation\n\nProlonged exposure\n\nProgressive loss of viral viability and infectiousness\n\nTemperature\n\nHumidity\n\nUltraviolet radiation \n\nInfection still possible\n\nMore than 6 feet away\n\nPassing through a space an infectious person has left\n\nPrevention of transmission\n\nPhysical distancing \n\nWell-fitting masks\n\nAdequate ventilation\n\nAvoidance of crowded indoor spaces\n\nhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00869-2/fulltext\n\n\nhttps://www.nytimes.com/2021/05/07/opinion/coronavirus-airborne-transmission.html\n\nHistory\n\nCDC, masks, 19th April 2020\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover-guidance.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprevent-getting-sick%2Fcloth-face-cover.html\n\nWHO, masks, 5th June 2020\n\nhttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks\n\nhttps://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---5-june-2020\n\nVaccine factors\n\nhttps://www.theguardian.com/world/live/2021/may/11/coronavirus-live-news-india-variant-of-concern-globally-says-who-pfizer-vaccine-approved-for-us-12-15-year-olds\n\nAstraZeneca, 20 manufacturing partners around the world\n\nWith which it has shared the Covid-19 vaccine technology\n\nIndia\u2019s Serum Institute, has supplied 300m doses so far to 165 countries\n\n90% of India\u2019s vaccines so far\n\nProviding 98% of the supply to Covax\n\nPledged not-for-profit basis for the duration\n\nAstraZeneca lost money first three months of the year\n\nPfizer and Moderna are on course to make $45bn (\u00a332bn) collectively from their coronavirus vaccines this year", "link": "https://www.youtube.com/watch?v=1PGGU4RYyAg", "date_published": "2021-05-12 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]